Drug

SP-26

Fibromyalgia

Zylö Therapeutics Joint Venture

Market Opportunity

Fibromyalgia

  • Fibromyalgia and multiple other indications

Technology

  • Clinical development of ketamine using ZTI’s Z-pod technology
  • Novel time-release topical formulation
  • Dosage and time-release ketamine implant
Previous Drug
Next Drug

Applications

  • Time-released, dosage-controlled formulation of
    ketamine
  • Will time-release diminish the hallucinogenic effects of these psychedelics
  • Positive toxicology results
  • Z-pod shown to hold and distribute ketamine
  • Efficacy study in animals underway

Get more information on Silo Pharma. Sign up for email alerts online.

SIGN UP